| PABSI | Pseudomonas aeruginosa bloodstream infection |
| ICU | intensive care unit |
| WHO | World Health Organization |
| CRPA | carbapenem-resistant P. aeruginosa |
| CSPA | carbapenem-susceptible P. aeruginosa |
| PRISMA-ScR | Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews |
| ECMO | extracorporeal membrane oxygenation |
| APACHE | Acute Physiology and Chronic Health Evaluation |
| SOFA | Sequential Organ Failure Assessment |
| MDR | multi-drug resistant |
| PTA | probability of target attainment |
| PCT | procalcitonin |
| CRP | C-reactive protein |
| ANC | absolute neutrophil count |
| TTP | time-to-positivity |
| DTRPA | Difficult-to-treat P. aeruginosa |